Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.

Yi BR, Hwang KA, Aboody KS, Jeung EB, Kim SU, Choi KC.

Stem Cell Res. 2014 Jan;12(1):36-48. doi: 10.1016/j.scr.2013.09.010. Epub 2013 Oct 1.

2.

Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.

Yi BR, Park MA, Lee HR, Kang NH, Choi KJ, Kim SU, Choi KC.

Mol Oncol. 2013 Jun;7(3):543-54. doi: 10.1016/j.molonc.2013.01.004. Epub 2013 Jan 19.

4.
5.

Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.

Kim KY, Yi BR, Lee HR, Kang NH, Jeung EB, Kim SU, Choi KC.

Int J Oncol. 2012 Apr;40(4):1097-104. doi: 10.3892/ijo.2011.1288. Epub 2011 Dec 8.

6.
7.

Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.

Yi BR, Hwang KA, Kang NH, Kim SU, Jeung EB, Kim HC, Choi KC.

Cancer Gene Ther. 2012 Sep;19(9):644-51. doi: 10.1038/cgt.2012.45. Epub 2012 Jul 13.

PMID:
22790964
8.

Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.

Yi BR, Kim SU, Choi KC.

Int J Oncol. 2015 Jul;47(1):171-8. doi: 10.3892/ijo.2015.2999. Epub 2015 May 11.

PMID:
25963746
9.

Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.

Yi BR, Kim SU, Kim YB, Lee HJ, Cho MH, Choi KC.

Oncol Rep. 2012 Jun;27(6):1823-8. doi: 10.3892/or.2012.1721. Epub 2012 Mar 13.

PMID:
22426744
10.

Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.

Kang W, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM.

Oncol Rep. 2013 Sep;30(3):1101-6. doi: 10.3892/or.2013.2584. Epub 2013 Jul 3.

PMID:
23828015
11.

Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects.

Yi BR, O SN, Kang NH, Hwang KA, Kim SU, Jeung EB, Kim YB, Heo GJ, Choi KC.

Int J Oncol. 2011 Oct;39(4):833-9. doi: 10.3892/ijo.2011.1126. Epub 2011 Jul 15.

PMID:
21769425
12.

Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice.

Lee HJ, Doo SW, Kim DH, Cha YJ, Kim JH, Song YS, Kim SU.

Cancer Lett. 2013 Jul 10;335(1):58-65. doi: 10.1016/j.canlet.2013.01.048. Epub 2013 Feb 4.

PMID:
23391716
13.

Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.

Kim DJ, Yi BR, Lee HR, Kim SU, Choi KC.

Oncol Rep. 2013 Sep;30(3):1129-36. doi: 10.3892/or.2013.2564. Epub 2013 Jun 25.

PMID:
23807450
14.
16.

Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.

Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung EB, Kim SU, Choi KC.

Cancer Gene Ther. 2012 Jun;19(6):412-9. doi: 10.1038/cgt.2012.15. Epub 2012 Apr 13.

PMID:
22498724
17.
18.

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.

Joo KM, Park IH, Shin JY, Jin J, Kang BG, Kim MH, Lee SJ, Jo MY, Kim SU, Nam DH.

Mol Ther. 2009 Mar;17(3):570-5. doi: 10.1038/mt.2008.290. Epub 2009 Jan 6.

19.

Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.

Lee JY, Lee DH, Kim HA, Choi SA, Lee HJ, Park CK, Phi JH, Wang KC, Kim SU, Kim SK.

J Neurooncol. 2014 Jan;116(1):49-57. doi: 10.1007/s11060-013-1264-6. Epub 2013 Oct 11.

PMID:
24113876
20.

Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.

Ito S, Natsume A, Shimato S, Ohno M, Kato T, Chansakul P, Wakabayashi T, Kim SU.

Cancer Gene Ther. 2010 May;17(5):299-306. doi: 10.1038/cgt.2009.80. Epub 2009 Nov 6.

PMID:
19893595
Items per page

Supplemental Content

Write to the Help Desk